Author! Author! Do All Scientific Papers Really Need To Identify So Many Of Them?

Researchers hold mixed opinions, with some advocating a streamlined approach that credits only germane contributors Geophysicist Marcia McNutt routinely reads a stack of journals ranging from the Journal of Geophysical research to Science and Nature. When she reads a paper in any of these publications, she usually feels safe making a few assumptions about the authors listed on the paper. "I usually assume the first author is the person who actually did the research," says McNutt, a professo

Written byKathryn Phillips
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"I usually assume the first author is the person who actually did the research," says McNutt, a professor of earth and planetary sciences at the Massachusetts Institute of Technology. "I assum if there is a senior person who is last author, whether that's second or thid, that that is the person who probably wrote the proposal to fund the research and had the idea to begin with, but generally did not personally carry out the research.

"And then, if there is an intermdeiate author, I usually assume that is a person who had some sort of significant input--such as providing a key data set or perhaps working on some key subset of the problem--but was not the person who physically wrote the paper and did more than 50 percent of the research."

McNutt's assumptions are typical. She reads the unspoken messages of the order of authorship the way most scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies